부산대학교 도서관

Tozzi R.; Casarin J.; Garruto-Campanile R.; Majd H. S.; Morotti M.

Gynecologic Oncology. 148:74-78

Tozzi R.; Hardern K.; Gubbala K.; Garruto Campanile R.; Soleymani majd H.

Gynecologic Oncology. 144:564-570

Tozzi R; Traill Z; Garruto Campanile R; Ferrari F; Soleymani Majd H; Nieuwstad J; Hardern K; Gubbala K

Gynecologic Oncology. 143:35-39

Pathiraja P. N. J.; Garruto-Campanile R.; Tozzi R.

Int J Surg Oncol

Tozzi, R.; Soleymani majd, H.; Garruto Campanile, R.; Desgro, M.; Morotti, M.; Casarin, J.

Gynecologic Oncology. 149:112-113

Garruto Campanile, R.; Soleymani Majd, H.; Casarin, J.; Morotti, M.; Tozzi, R.

Gynecologic Oncology. 149:237-237

Tozzi, R.; Soleymani Majd, H.; Ferrari, F.; Garruto Campanile, R.

Gynecologic Oncology. 149:81-81

Ferrari, F.; Fachechi, G.; Gubbala, K.; Soleymani majd, H.; Garruto Campanile, R.; ce:underline>Tozzi, R.

Gynecologic Oncology. 137:73-73

Tozzi, R; Lavra, F; Cassese, T; Campanile, Garruto R; Pedicini, V; Bignardi, M; Scorsetti, M; Bertuzzi, A

BJOG: An International Journal of Obstetrics and Gynaecology. Apr 01, 2009 116(5):688-692

Tozzi R.; Garruto Campanile R.

Gynecological Surgery. 4

Tozzi R.; Casarin J.; Belcher E.; Garruto Campanile R.; Ismail L.; Soleymani Majd H.; Morotti M.; Desgro M.

Journal of Minimally Invasive Gynecology. 25:1148

Tozzi R; Department of Gynaecologic Oncology, Division of Women's and Children, Churchill Hospital, Oxford, UK. Electronic address: roberto.tozzi@wrh.ox.ac.uk.; Casarin J; Department of Gynaecologic Oncology, Division of Women's and Children, Churchill Hospital, Oxford, UK; Department of Obstetrics and Gynecology, University of Insubria, Varese, Italy.; Baysal A; Department of Gynaecologic Oncology, Division of Women's and Children, Churchill Hospital, Oxford, UK.; Pinelli C; Department of Gynaecologic Oncology, Division of Women's and Children, Churchill Hospital, Oxford, UK; Department of Obstetrics and Gynecology, University of Insubria, Varese, Italy.; Matak L; Department of Gynaecologic Oncology, Division of Women's and Children, Churchill Hospital, Oxford, UK; Department of Obstetrics and Gynaecology, General Hospital Zadar, Croatia.; Ghanbarzadeh N; Department of Gynaecologic Oncology, Division of Women's and Children, Churchill Hospital, Oxford, UK; Department of Obstetrics and Gynaecology, Birjand University of Medical Sciences, Iran.; Alazzam M; Department of Gynaecologic Oncology, Division of Women's and Children, Churchill Hospital, Oxford, UK.; Garruto-Campanile R; Department of Gynaecologic Oncology, Division of Women's and Children, Churchill Hospital, Oxford, UK.; Majd HS; Department of Gynaecologic Oncology, Division of Women's and Children, Churchill Hospital, Oxford, UK.; Kilic Y; Department of Gynaecologic Oncology, Division of Women's and Children, Churchill Hospital, Oxford, UK.; Morotti M; Department of Gynaecologic Oncology, Division of Women's and Children, Churchill Hospital, Oxford, UK.

Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 0375672 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7654 (Electronic) Linking ISSN: 03012115 NLM ISO Abbreviation: Eur J Obstet Gynecol Reprod Biol Subsets: MEDLINE

Hu Z; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.; Artibani M; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK; Gene Regulatory Networks in Development and Disease Laboratory, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DS, UK.; Alsaadi A; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.; Wietek N; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK; Department of Gynecological Oncology, Churchill Hospital, Oxford University Hospitals, Oxford OX3 7LE, UK.; Morotti M; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK; Department of Gynecological Oncology, Churchill Hospital, Oxford University Hospitals, Oxford OX3 7LE, UK.; Shi T; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.; Zhong Z; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.; Santana Gonzalez L; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.; El-Sahhar S; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.; Carrami EM; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.; Mallett G; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.; Feng Y; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK.; Masuda K; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.; Zheng Y; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.; Chong K; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK.; Damato S; Department of Histopathology, Oxford University Hospitals, Oxford OX3 9DU, UK.; Dhar S; Department of Histopathology, Oxford University Hospitals, Oxford OX3 9DU, UK.; Campo L; Department of Oncology, University of Oxford, Oxford OX3 7DQ, UK.; Garruto Campanile R; Department of Gynecological Oncology, Churchill Hospital, Oxford University Hospitals, Oxford OX3 7LE, UK.; Soleymani Majd H; Department of Gynecological Oncology, Churchill Hospital, Oxford University Hospitals, Oxford OX3 7LE, UK.; Rai V; Department of Gynaecology, Oxford University Hospitals NHS Trust, Oxford OX3 9DU, UK.; Maldonado-Perez D; Oxford Radcliffe Biobank, Nuffield Department of Surgical Sciences, University of Oxford, Oxford OX3 9DU, UK; NIHR Oxford Biomedical Research Centre, Second Floor, Unipart House Business Centre, Oxford OX4 2PG, UK.; Jones S; Oxford Radcliffe Biobank, Nuffield Department of Surgical Sciences, University of Oxford, Oxford OX3 9DU, UK.; Cerundolo V; Human Immunology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK.; Sauka-Spengler T; Gene Regulatory Networks in Development and Disease Laboratory, MRC Weatherall Institute of Molecular Medicine, Radcliffe Department of Medicine, University of Oxford, Oxford OX3 9DS, UK.; Yau C; Wellcome Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7BN, UK; Centre for Computational Biology, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham B15 2TT, UK; Division of Informatics, Imaging and Data Sciences, Faculty of Biology Medicine and Health, The University of Manchester, Manchester M13 9PT, UK; Alan Turing Institute, London NW1 2DB, UK. Electronic address: christopher.yau@manchester.ac.uk.; Ahmed AA; Ovarian Cancer Cell Laboratory, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK; Nuffield Department of Women's & Reproductive Health, University of Oxford, Oxford OX3 9DU, UK; Department of Gynecological Oncology, Churchill Hospital, Oxford University Hospitals, Oxford OX3 7LE, UK. Electronic address: ahmed.ahmed@wrh.ox.ac.uk.

Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

Tozzi, R.; Casarin, J.; Baysal, A.; Garruto-Campanile, R.; Majd, H. S.; Kilic, Y.; Morotti, M.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY; JUN 2019, 126 p98-p98, 1p. Supplement: 2

Giannice, R.; Manek, S.; Soleymani, H.; Guarnerio, P.; Campanile, R. Garruto; Dhar, S.; Valenti, G.; Morotti, M.; Sereni, M. I.; Tozzi, R.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER; NOV 2017, 27 p1094-p1094, 1p. Supplement: 4